Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5411
Revised: February 25, 2014
Accepted: March 6, 2014
Published online: May 14, 2014
Processing time: 206 Days and 14 Hours
Non-coding RNAs (ncRNAs) play key roles in development, proliferation, differentiation and apoptosis. Altered ncRNA expression is associated with gastric cancer occurrence, invasion, and metastasis. Moreover, aberrant expression of microRNAs (miRNAs) is significantly related to gastric cancer tumor stage, size, differentiation and metastasis. MiRNAs interrupt cellular signaling pathways, inhibit the activity of tumor suppressor genes, and affect the cell cycle in gastric cancer cells. Some miRNAs, including miR-21, miR-106a and miR-421, could be potential markers for the diagnosis of gastric cancer. Long non-coding RNAs (lncRNAs), a new research hotspot among cancer-associated ncRNAs, play important roles in epigenetic, transcriptional and post-transcriptional regulation. Several gastric cancer-associated lncRNAs, such as CCAT1, GACAT1, H19, and SUMO1P3, have been explored. In addition, Piwi-interacting RNAs, another type of small ncRNA that is recognized by gastroenterologists, are involved in gastric carcinogenesis, and piR-651/823 represents an efficient diagnostic biomarker of gastric cancer that can be detected in the blood and gastric juice. Small interfering RNAs also function in post-transcriptional regulation in gastric cancer and might be useful in gastric cancer treatment.
Core tip: Non-coding RNAs (ncRNAs) are closely associated with gastric cancer occurrence, invasion, and metastasis. MicroRNAs interrupt cellular signaling pathways, inhibit the activity of tumor suppressor genes, and affect the cell cycle in gastric cancer cells. Long non-coding RNAs (lncRNAs) represent a new research hotspot in the field of gastric cancer-associated ncRNAs. The global lncRNA expression profile in gastric cancer has been determined. In addition, Piwi-interacting RNAs are involved in gastric carcinogenesis. Small interfering RNAs function as post-transcriptional regulators in gastric cancer, and they might be used for the treatment of gastric cancer.